Double-blind evaluation of mazindol in refractory obesity.
D001066:Appetite / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008454:Mazindol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos
D007211:Indoles; D010919:Placebos; D008454:Mazindol